Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	11.02B -28.4%
Revenue (ttm)	663.57M +26.2%
Net Income	202.44M +18.7%
EPS	1.47 +17.0%
Shares Out	137.75M
PE Ratio	54.50
Forward PE	n/a
Dividend	0.80 (0.99%)
Ex-Dividend Date	May 26, 2026

Volume	356,020
Open	80.66
Previous Close	80.66
Day's Range	79.20 - 81.23
52-Week Range	79.80 - 132.94
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 746
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2025, SHA:688198's revenue was 620.15 million, an increase of 23.57% compared to the previous year's 501.88 million. Earnings were 193.57 million, an increase of 32.28%.